vs

Side-by-side financial comparison of GLOBALFOUNDRIES Inc. (GFS) and DENTSPLY SIRONA Inc. (XRAY). Click either name above to swap in a different company.

GLOBALFOUNDRIES Inc. is the larger business by last-quarter revenue ($1.7B vs $961.0M, roughly 1.8× DENTSPLY SIRONA Inc.). GLOBALFOUNDRIES Inc. runs the higher net margin — 14.8% vs -15.2%, a 29.9% gap on every dollar of revenue. On growth, DENTSPLY SIRONA Inc. posted the faster year-over-year revenue change (6.2% vs -2.9%). Over the past eight quarters, DENTSPLY SIRONA Inc.'s revenue compounded faster (0.4% CAGR vs -4.3%).

GlobalFoundries Inc. is a multinational semiconductor contract manufacturing and design company domiciled in the Cayman Islands and headquartered in Malta, New York. Created by the divestiture of the manufacturing arm of AMD in March 2009, the company was privately owned by Mubadala Investment Company, a sovereign wealth fund of the United Arab Emirates, until an initial public offering (IPO) in October 2021. Mubadala remains the majority owner of the company with an 82% stake.

Dentsply Sirona Inc. is an American dental equipment manufacturer and dental consumables producer that markets its products in over 120 countries. It has factories in 21 countries. The present company is largely the result of a merger in 1993 in which Gendex Corporation acquired Dentsply International Inc. for $590 million.

GFS vs XRAY — Head-to-Head

Bigger by revenue
GFS
GFS
1.8× larger
GFS
$1.7B
$961.0M
XRAY
Growing faster (revenue YoY)
XRAY
XRAY
+9.1% gap
XRAY
6.2%
-2.9%
GFS
Higher net margin
GFS
GFS
29.9% more per $
GFS
14.8%
-15.2%
XRAY
Faster 2-yr revenue CAGR
XRAY
XRAY
Annualised
XRAY
0.4%
-4.3%
GFS

Income Statement — Q3 FY2025 vs Q4 FY2025

Metric
GFS
GFS
XRAY
XRAY
Revenue
$1.7B
$961.0M
Net Profit
$249.0M
$-146.0M
Gross Margin
24.8%
46.1%
Operating Margin
11.6%
-14.5%
Net Margin
14.8%
-15.2%
Revenue YoY
-2.9%
6.2%
Net Profit YoY
39.9%
66.0%
EPS (diluted)
$0.44
$-0.74

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
GFS
GFS
XRAY
XRAY
Q4 25
$961.0M
Q3 25
$1.7B
$904.0M
Q2 25
$1.7B
$936.0M
Q1 25
$1.6B
$879.0M
Q4 24
$905.0M
Q3 24
$1.7B
$951.0M
Q2 24
$1.6B
$984.0M
Q1 24
$1.5B
$953.0M
Net Profit
GFS
GFS
XRAY
XRAY
Q4 25
$-146.0M
Q3 25
$249.0M
$-427.0M
Q2 25
$228.0M
$-45.0M
Q1 25
$211.0M
$20.0M
Q4 24
$-430.0M
Q3 24
$178.0M
$-494.0M
Q2 24
$155.0M
$-4.0M
Q1 24
$134.0M
$18.0M
Gross Margin
GFS
GFS
XRAY
XRAY
Q4 25
46.1%
Q3 25
24.8%
48.8%
Q2 25
24.2%
52.4%
Q1 25
22.4%
53.0%
Q4 24
49.3%
Q3 24
23.8%
52.1%
Q2 24
24.2%
51.9%
Q1 24
25.4%
53.1%
Operating Margin
GFS
GFS
XRAY
XRAY
Q4 25
-14.5%
Q3 25
11.6%
-24.1%
Q2 25
11.6%
-13.7%
Q1 25
9.5%
7.2%
Q4 24
-56.2%
Q3 24
10.6%
-48.6%
Q2 24
9.5%
5.1%
Q1 24
9.5%
4.4%
Net Margin
GFS
GFS
XRAY
XRAY
Q4 25
-15.2%
Q3 25
14.8%
-47.2%
Q2 25
13.5%
-4.8%
Q1 25
13.3%
2.3%
Q4 24
-47.5%
Q3 24
10.2%
-51.9%
Q2 24
9.5%
-0.4%
Q1 24
8.7%
1.9%
EPS (diluted)
GFS
GFS
XRAY
XRAY
Q4 25
$-0.74
Q3 25
$0.44
$-2.14
Q2 25
$0.41
$-0.22
Q1 25
$0.38
$0.10
Q4 24
$-2.09
Q3 24
$0.32
$-2.46
Q2 24
$0.28
$-0.02
Q1 24
$0.24
$0.09

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
GFS
GFS
XRAY
XRAY
Cash + ST InvestmentsLiquidity on hand
$2.0B
$326.0M
Total DebtLower is stronger
$2.3B
Stockholders' EquityBook value
$11.8B
$1.3B
Total Assets
$16.7B
$5.4B
Debt / EquityLower = less leverage
1.70×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
GFS
GFS
XRAY
XRAY
Q4 25
$326.0M
Q3 25
$2.0B
$363.0M
Q2 25
$1.8B
$359.0M
Q1 25
$1.6B
$398.0M
Q4 24
$272.0M
Q3 24
$2.3B
$296.0M
Q2 24
$2.2B
$279.0M
Q1 24
$2.2B
$291.0M
Total Debt
GFS
GFS
XRAY
XRAY
Q4 25
$2.3B
Q3 25
Q2 25
Q1 25
Q4 24
$1.7B
Q3 24
Q2 24
Q1 24
Stockholders' Equity
GFS
GFS
XRAY
XRAY
Q4 25
$1.3B
Q3 25
$11.8B
$1.5B
Q2 25
$11.5B
$2.0B
Q1 25
$11.1B
$2.0B
Q4 24
$1.9B
Q3 24
$11.6B
$2.5B
Q2 24
$11.3B
$3.1B
Q1 24
$11.3B
$3.3B
Total Assets
GFS
GFS
XRAY
XRAY
Q4 25
$5.4B
Q3 25
$16.7B
$5.7B
Q2 25
$16.8B
$6.1B
Q1 25
$16.5B
$6.0B
Q4 24
$5.8B
Q3 24
$18.1B
$6.6B
Q2 24
$6.9B
Q1 24
$7.1B
Debt / Equity
GFS
GFS
XRAY
XRAY
Q4 25
1.70×
Q3 25
Q2 25
Q1 25
Q4 24
0.90×
Q3 24
Q2 24
Q1 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
GFS
GFS
XRAY
XRAY
Operating Cash FlowLast quarter
$595.0M
$101.0M
Free Cash FlowOCF − Capex
$60.0M
FCF MarginFCF / Revenue
6.2%
Capex IntensityCapex / Revenue
4.3%
Cash ConversionOCF / Net Profit
2.39×
TTM Free Cash FlowTrailing 4 quarters
$104.0M

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
GFS
GFS
XRAY
XRAY
Q4 25
$101.0M
Q3 25
$595.0M
$79.0M
Q2 25
$431.0M
$48.0M
Q1 25
$331.0M
$7.0M
Q4 24
$87.0M
Q3 24
$375.0M
$141.0M
Q2 24
$402.0M
$208.0M
Q1 24
$488.0M
$25.0M
Free Cash Flow
GFS
GFS
XRAY
XRAY
Q4 25
$60.0M
Q3 25
$40.0M
Q2 25
$16.0M
Q1 25
$-12.0M
Q4 24
$36.0M
Q3 24
$98.0M
Q2 24
$156.0M
Q1 24
$-9.0M
FCF Margin
GFS
GFS
XRAY
XRAY
Q4 25
6.2%
Q3 25
4.4%
Q2 25
1.7%
Q1 25
-1.4%
Q4 24
4.0%
Q3 24
10.3%
Q2 24
15.9%
Q1 24
-0.9%
Capex Intensity
GFS
GFS
XRAY
XRAY
Q4 25
4.3%
Q3 25
4.3%
Q2 25
3.4%
Q1 25
2.2%
Q4 24
5.6%
Q3 24
4.5%
Q2 24
5.3%
Q1 24
3.6%
Cash Conversion
GFS
GFS
XRAY
XRAY
Q4 25
Q3 25
2.39×
Q2 25
1.89×
Q1 25
1.57×
0.35×
Q4 24
Q3 24
2.11×
Q2 24
2.59×
Q1 24
3.64×
1.39×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

GFS
GFS

Smart Mobile Devices$752.0M45%
Automotive$306.0M18%
Home And Industrial Io T$258.0M15%
Goods Or Services Transferred Over Time$198.0M12%
Communications Infrastructure Datacenter$175.0M10%

XRAY
XRAY

Essential Dental Solutions$372.0M39%
Equipment And Instruments$160.0M17%
Implants And Prosthetics$150.0M16%
CADCAM$139.0M14%
Wellspect Healthcare$88.0M9%
Orthodontics$52.0M5%

Related Comparisons